Consistent with these findings, we found that the levels of NFκB1 expression in pancreatic cancer CSCs were significantly increased, and ectopic expression of NFκB1 could induce gemcitabine resistance in CSCs and non-CSCs. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.